Gerdes C, Fisher R M, Nicaud V, Boer J, Humphries S E, Talmud P J, Faergeman O
Department of Medicine and Cardiology A, Aarhus Amtssygehus University Hospital, Denmark.
Circulation. 1997 Aug 5;96(3):733-40. doi: 10.1161/01.cir.96.3.733.
Variations at the DNA level with moderate effects on biochemical variables may be important for the occurrence of disease at the population level, if they are common. Two mutations in the LPL gene, N9 and S291, are associated with variation in fasting plasma concentrations of HDL cholesterol (HDL-C) and triglycerides (TG). We investigated whether these mutants were more frequent in offspring of cases with premature coronary disease and analyzed the effects on fasting plasma lipids and postprandial TG.
Students with and without paternal history of myocardial infarction (cases and control subjects [controls]) were studied in the European Atherosclerosis Research Studies I and II (EARS-I and -II). Allelic frequencies for the N9 and S291 mutations did not differ between cases and control subjects. The N9 mutation was identified in 4.2% of all subjects in EARS-I, and carriers had higher fasting TG levels (P<.001) than noncarriers. In an oral fat tolerance test, there were no differences in postprandial TG between carriers and noncarriers of the N9 allele. The S291 mutation was identified in 3.1% of all subjects in EARS-I, and carriers had lower fasting HDL-C levels (P<.005) than noncarriers. There was a significant interaction between S291 genotype and body mass index on fasting TG levels (P<.01). In the cases, carriers of the S291 allele had higher TG levels 6 hours postprandially (P<.04) than did noncarriers.
The two LPL mutations are common and may predispose to elevated TG and decreased HDL-C concentrations, even in young subjects. In the case of the S291 mutation, this effect appears to be mediated via delayed postprandial TG clearance. Moreover, even moderate obesity potentiates the TG-raising and HDL-lowering effects associated with the S291 allele.
如果DNA水平的变异对生化变量有中等程度的影响且较为常见,那么它们可能在人群层面的疾病发生中具有重要意义。脂蛋白脂肪酶(LPL)基因中的两个突变,N9和S291,与空腹血浆高密度脂蛋白胆固醇(HDL-C)和甘油三酯(TG)浓度的变异有关。我们研究了这些突变体在早发冠心病患者后代中是否更常见,并分析了它们对空腹血脂和餐后TG的影响。
在欧洲动脉粥样硬化研究I和II(EARS-I和-II)中,对有和没有父亲心肌梗死病史的学生(病例组和对照组[对照])进行了研究。病例组和对照组之间N9和S291突变的等位基因频率没有差异。在EARS-I中,4.2%的所有受试者中鉴定出N9突变,携带者的空腹TG水平高于非携带者(P<0.001)。在口服脂肪耐量试验中,N9等位基因的携带者和非携带者之间餐后TG没有差异。在EARS-I中,3.1%的所有受试者中鉴定出S291突变,携带者的空腹HDL-C水平低于非携带者(P<0.005)。S291基因型与体重指数在空腹TG水平上存在显著交互作用(P<0.01)。在病例组中,S291等位基因的携带者餐后6小时的TG水平高于非携带者(P<0.04)。
这两个LPL突变很常见,即使在年轻受试者中也可能易导致TG升高和HDL-C浓度降低。就S291突变而言,这种效应似乎是通过餐后TG清除延迟介导的。此外,即使是中度肥胖也会增强与S291等位基因相关的TG升高和HDL降低效应。